On Wednesday, June 24, the Foundation hosted a special conversation with Jill O’Donnell-Tormey, PhD, CEO of the Cancer Research Institute (CRI) and the Foundation’s Chief Scientific Officer, Jessica Foley, PhD.
The Cancer Research Institute is a leader in the field of cancer immunotherapy and important partner to the Foundation. Drs. O’Donnell-Tormey and Foley discussed the lifesaving potential of cancer immunotherapy and the ways that CRI and the Foundation are working together to advance exciting research, through a lens of the new COVID-19 environment.
Cancer Immunotherapy Treatment and Research in a COVID-19 World
Jill O’Donnell-Tormey, PhD
Chief Executive Officer and Director of Scientific Affairs, Cancer Research Institute
Jessica Foley, PhD
Chief Scientific Officer, Focused Ultrasound Foundation
Wednesday, June 24, 2020
About the Speakers
Jill O’Donnell-Tormey, PhD
Jill O’Donnell-Tormey, PhD, is chief executive officer and director of scientific affairs of the Cancer Research Institute (CRI), a nonprofit organization founded in 1953 that is today the global leader in supporting and coordinating research aimed at harnessing the immune system’s power to conquer all cancers. She joined the organization in 1987, and has been chief executive since 1993. Prior to joining CRI, she served as a research associate in the department of medicine at Cornell University Medical College and as a postdoctoral fellow in the laboratory of cellular physiology and immunology at The Rockefeller University.
Jessica Foley, PhD
Jessica Foley, PhD joined the Foundation in 2012 after a more than 11-year career in the field of focused ultrasound that spanned academic, industrial and government worlds. As Chief Scientific Officer, Foley guides the strategy, development, and implementation of the scientific and research programs and activities within the Foundation, and aligns these with communications and development efforts. She also leads alliance-building efforts with external stakeholders including (but not limited to) governmental policymakers, regulatory agencies, and disease-specific foundations whose interests are complementary to those of the Foundation. She is a representative and advocate for the Foundation and the focused ultrasound community among a wide variety of stakeholders. Her experience prior to the Foundation included several years with InSightec as the Neuro Projects Manager and Clinical Marketing Manager; Senior Scientist at Medtronic; and serving as a 2011-2012 AAAS Science and Technology.